0001493152-24-012648.txt : 20240402 0001493152-24-012648.hdr.sgml : 20240402 20240402091408 ACCESSION NUMBER: 0001493152-24-012648 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 16 CONFORMED PERIOD OF REPORT: 20240402 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240402 DATE AS OF CHANGE: 20240402 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InspireMD, Inc. CENTRAL INDEX KEY: 0001433607 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 262123838 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-35731 FILM NUMBER: 24812423 BUSINESS ADDRESS: STREET 1: 4 MENORAT HAMAOR ST. CITY: TEL AVIV STATE: L3 ZIP: 6744832 BUSINESS PHONE: (888) 776-6804 MAIL ADDRESS: STREET 1: 4 MENORAT HAMAOR ST. CITY: TEL AVIV STATE: L3 ZIP: 6744832 FORMER COMPANY: FORMER CONFORMED NAME: Saguaro Resources, Inc. DATE OF NAME CHANGE: 20080428 8-K 1 form8-k.htm
false 0001433607 0001433607 2024-04-02 2024-04-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): April 2, 2024

 

InspireMD, Inc.

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

(State or Other Jurisdiction of Incorporation)

 

001-35731   26-2123838

(Commission

File Number)

 

(IRS Employer

Identification No.)

 

4 Menorat Hamaor St.

Tel Aviv, Israel

  6744832
(Address of Principal Executive Offices)   (Zip Code)

 

(888) 776-6804

(Registrant’s Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Stock, par value $0.0001 per share   NSPR   The Nasdaq Capital Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 
 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Slosman Amendment

 

On April 1, 2024, InspireMD, Inc. (the “Company”) and Marvin Slosman, the Company’s chief executive officer, entered into the fourth amendment (the “Slosman Amendment”) to that certain Employment Agreement dated as of December 19, 2019, as amended on December 31, 2019, November 8, 2021, and January 5, 2023 (as amended, the “Slosman Agreement”), in order to amend certain terms relating to the termination of Mr. Slosman’s employment in the event of a change of control of the Company.

 

As set forth in the Slosman Amendment, in the event of (i) a termination without Cause (as defined in the Slosman Agreement) or (ii) the Slosman Agreement is not renewed, during the three month period before or within twelve months following a Change in Control (as defined in the Slosman Agreement), subject to the conditions set forth in the Slosman Amendment, Mr. Slosman shall be entitled to (1) severance pay equal to Mr. Slosman’s base salary for twenty-four months, (2) the equivalent of two times Mr. Slosman’s entire Performance Bonus (as defined in the Slosman Agreement) based on achievement of the applicable performance criteria/financial results in the year prior to the year of termination, (3) an additional bonus amount calculated as the product of (A) the Performance Bonus that Mr. Slosman would have received had his employment not been terminated during such year and (B) a fraction, the numerator of which is the number of days Mr. Slosman was employed by the Company during the year of termination and the denominator of which is the number of days in such year, and (4) exercise any outstanding stock options or stock appreciation rights until the earlier of (A) the last date on which such stock options or stock appreciation rights could have been exercised pursuant to the terms of the applicable award agreement, irrespective of Mr. Slosman’s termination of employment; and (B) the date that is two years following his employment termination date ((i) – (v) collectively, the “Slosman Change of Control Severance Payments”).

 

In addition to the Slosman Change of Control Severance Payments, in the event of a Change of Control, to the fullest extent permitted by the Company’s then-current benefit plans, Mr. Slosman shall be entitled to continuation of health, dental, vision and life insurance coverage, (but not pension, retirement, profit-sharing, severance or similar compensatory benefits), for Mr. Slosman and his eligible dependents substantially similar to coverage they were receiving or which they were entitled to immediately prior to the termination of Mr. Slosman’s employment for the lesser of twenty-four months after termination or until Mr. Slosman secures coverage from new employment.

 

Except as amended by the Slosman Amendment, all other provisions of the Slosman Agreement remain in full force and effect.

 

 
 

 

Shore Amendment

 

On April 1, 2024, the Company and Craig Shore, the Company’s chief financial officer, chief administrative officer, secretary and treasurer, entered into the eighth amendment (the “Shore Amendment”) to that certain amended and Restated Employment Agreement dated as of May 5, 2014, as amended on January 5, 2015, July 25, 2016, March 25, 2019, August 14, 2020, November 4, 2021, January 17, 2022 and January 18, 2023 (as amended, the “Shore Agreement”), in order to amend certain terms relating to the termination of Mr. Shore’s employment in the event of a change of control of the Company.

 

As set forth in the Shore Amendment, in the event of (i) a termination without Cause (as defined in the Shore Agreement) or (ii) the Shore Agreement is not renewed, during the three month period before or within twelve months following a Change in Control (as defined in the Shore Agreement), subject to the conditions set forth in the Shore Amendment, Mr. Shore shall be entitled to (1) severance pay equal to Mr. Shore’s base salary for twelve months, (2) the equivalent of Mr. Shore’s entire Annual Bonus (as defined in the Shore Agreement) based on achievement of the applicable performance criteria/financial results in the year prior to the year of termination, (3) an additional bonus amount calculated as the product of (A) the Annual Bonus that Mr. Shore would have received had his employment not been terminated during such year and (B) a fraction, the numerator of which is the number of days Mr. Shore was employed by the Company during the year of termination and the denominator of which is the number of days in such year, and (4) exercise any future stock options or stock appreciation rights until the earlier of (A) the last date on which such stock options or stock appreciation rights could have been exercised pursuant to the terms of the applicable award agreement, irrespective of Mr. Shore’s termination of employment; and (B) the date that is one year following his employment termination date ((i) – (v) collectively, the “Shore Change of Control Severance Payments”).

 

In addition, the Shore Change of Control Severance Payments (i) shall be paid in addition to payments related to any and all social, pension, retirement, profit-sharing, severance or similar compensatory benefits owed to and/or previously deposited into the relevant accounts of or for the benefit of, Mr. Shore as of the date of termination plus (A) a car allowance and (B) payments related to any and all social, pension, retirement, profit-sharing, severance or similar compensatory benefits that the Company would have been obligated to pay had Mr. Shore remained employed in the same position and at the same base salary for the 12 months immediately following the date of termination, as were in effect for the 12 months immediately preceding the date of termination and (ii) are in addition to (but without duplication of) Mr. Shore’s severance benefits that would be triggered by terminations without a Change in Control. Further, in the event of a Change of Control, to the fullest extent permitted by the Company’s then-current benefit plans, Mr. Shore shall be entitled to continuation of health, dental, vision and life insurance coverage, (but not pension, retirement, profit-sharing, severance or similar compensatory benefits), for Mr. Shore and his eligible dependents substantially similar to coverage they were receiving or which they were entitled to immediately prior to the termination of Mr. Shore’s employment for the lesser of twelve months after termination or until Mr. Shore secures coverage from new employment.

 

Except as amended by the Shore Amendment, all other provisions of the Shore Agreement remain in full force and effect.

 

The forgoing descriptions of the Slosman Amendment and the Shore Amendment do not purport to be complete and are qualified in their entirety by the full text of the Slosman Amendment and the Shore Amendment, a copies of which are filed as Exhibits 10.1 and 10.2, respectively, to this Current Report on Form 8-K.

 

Item 9.01 Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit
Number
  Description
10.1   Fourth Amendment to Employment Agreement, dated April 1, 2024, by and between InspireMD, Inc. and Marvin Slosman
10.2   Eighth Amendment to Employment Agreement, dated April 1, 2024, by and between InspireMD, Inc. and Craig Shore
104   Cover Page Interactive Data File (embedded within the Inline XBRL document)

 

 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  INSPIREMD, INC.
     
Date: April 2, 2024 By: /s/ Craig Shore
  Name:  Craig Shore
  Title: Chief Financial Officer

 

 

 

EX-10.1 2 ex10-1.htm

 

Exhibit 10.1

 

FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT

 

This FOURTH AMENDMENT TO EMPLOYMENT AGREEMENT (this “Amendment”), dated as of April 1, 2024, by and between Marvin Slosman (the “Executive”) and InspireMD, Inc. (the “Company”).

 

WHEREAS, the Company and Executive are parties to an Employment Agreement dated as of December 9, 2019, as amended by those amendments dated as of December 31, 2019, November 8, 2021, and January 5, 2023 (the “Agreement”); and

 

WHEREAS, the parties desire to amend the Agreement in certain respects;

 

NOW, THEREFORE, pursuant to Article V, Section G of the Agreement, and for good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and the Executive agree as follows:

 

1. Additional Payments in the event of a Change in Control. The third sentence of Article III, Section B(i) of the Agreement is hereby replaced in its entirety by the following:

 

In the event of a Change in Control (as defined below), if at any time the Executive is terminated, including by nonrenewal, upon or during the three (3) months before a Change of Control or the twelve (12) month period following a Change of Control other than a Termination for Cause, then the Executive’s termination, including by nonrenewal, shall be deemed a termination pursuant to Article III, Section B(ii).

 

The following sentences shall be added to Article III, Section B(ii), which provides for severance pay in the event of a Termination Without Cause or for Good Reason:

 

Additionally, in the event of a Termination Without Cause or for Good Reason, to the fullest extent permitted by the Company’s then-current benefit plans, subject to execution and timely return by the Executive of a release of claims in the form to be delivered by the Company, Executive shall be entitled to continuation of health, dental, vision and life insurance coverage, (but not pension, retirement, profit-sharing, severance or similar compensatory benefits), for the Executive and the Executive’s eligible dependents at the Company’s cost for substantially similar to coverage they were receiving or which they were entitled to immediately prior to the termination of the Executive’s employment for the lesser of twelve (12) months after termination or until the Executive secures coverage from new employment. The period of COBRA health care continuation coverage provided under Section 4980B of the Code shall run concurrently with the foregoing 12-month period. In order to receive such benefits, the Executive or his eligible dependents must continue to make any required co-payments, deductibles, premium sharing or other cost-splitting arrangements the Executive was otherwise paying immediately prior to the date of termination, and nothing herein shall require the Company to be responsible for such items. If the Executive is a “specified employee” under Section 409A, the full cost of the continuation or provision of employee group welfare benefits (other than medical or dental benefits) shall be paid by the Executive until the earliest to occur of (i) the Executive’s death or (ii) the first day of the seventh month following the Executive’s termination of employment, and such cost shall be reimbursed by the Company to, or on behalf of, the Executive in a lump sum cash payment on the earlier to occur of the Executive’s death or the first day of the seventh month following the Executive’s termination of employment, except that, as provided above, the Executive shall not receive reimbursement for any required co-payments, deductibles, premium sharing or other cost-splitting arrangements the Executive was otherwise paying immediately prior to the date of termination.

 

   
 

 

The following sentences shall be added at the end of Article III, Section B(ii) of the Agreement:

 

In the event of a Change in Control as defined by the LTIP, if at any time the Executive’s employment is terminated by the Company, including by nonrenewal, upon or during the three (3) months before or within the twelve (12) month period following a Change of Control other than a Termination for Cause, the Executive shall receive, subject to the execution and timely return by the Executive of a release of claims in the form to be delivered by the Company, which release shall, by its terms, be irrevocable no later than the expiration of any revocation rights afforded to Executive by applicable law, the following additional Change in Control benefits: (a) severance pay equal to the Executive’s Base Salary for an additional twenty-four (24) months, paid in one lump sum on the Company’s first regular payroll pay date that occurs after the expiration of the applicable revocation period for the release; (b) the equivalent of two times the Executive’s entire Performance Bonus based on achievement of the applicable performance criteria/financial results in the year prior to the year of termination, paid in one lump sum on the Company’s first regular payroll pay date that occurs after the expiration of the applicable revocation period for the release (for a total of two years’ worth of Performance Bonuses); (c) the amount equal to the product of (i) the Performance Bonus, paid at 100% target, for the calendar year in which his termination of employment occurs (assuming full achievement of all applicable goals under the Bonus Plan) that he would have received had his employment not been terminated during such year and (ii) a fraction, the numerator of which is the number of days the Executive was employed by the Company during the year of termination and the denominator of which is the number of days in such year, payable at the same time as such bonuses are payable to other executives under the Bonus Plan; and (d) in addition, the Executive may exercise any outstanding stock options or stock appreciation rights until the earlier of (x) the last date on which such stock options or stock appreciation rights could have been exercised pursuant to the terms of the applicable award agreement, irrespective of the Executive’s termination of employment, and (y) the date that is two (2) years following his employment termination date. Notwithstanding anything to the contrary herein, if any of the above additional Change in Control benefits is subject to Section 409A and the timing of Executive’s execution and delivery of the release could affect the calendar year in which any amount of such benefits is made because the termination date occurred toward the end of a calendar year, then no portion of such benefits shall be paid until the Company’s first payroll payment date in the year following the year in which the termination date occurs.

 

   
 

 

Additionally, in the event of a Change in Control as defined by the LTIP, to the fullest extent permitted by the Company’s then-current benefit plans, Executive shall be entitled to continuation of health, dental, vision and life insurance coverage, (but not pension, retirement, profit-sharing, severance or similar compensatory benefits), for the Executive and the Executive’s eligible dependents substantially similar to coverage they were receiving or which they were entitled to immediately prior to the termination of the Executive’s employment for the lesser of 24 months after termination or until the Executive secures coverage from new employment. The period of COBRA health care continuation coverage provided under Section 4980B of the Code shall run concurrently with the foregoing 24-month period. In order to receive such benefits, the Executive or his eligible dependents must continue to make any required co-payments, deductibles, premium sharing or other cost-splitting arrangements the Executive was otherwise paying immediately prior to the date of termination, and nothing herein shall require the Company to be responsible for such items. If the Executive is a “specified employee” under Section 409A, the full cost of the continuation or provision of employee group welfare benefits (other than medical or dental benefits) shall be paid by the Executive until the earliest to occur of (i) the Executive’s death or (ii) the first day of the seventh month following the Executive’s termination of employment, and such cost shall be reimbursed by the Company to, or on behalf of, the Executive in a lump sum cash payment on the earlier to occur of the Executive’s death or the first day of the seventh month following the Executive’s termination of employment, except that, as provided above, the Executive shall not receive reimbursement for any required co-payments, deductibles, premium sharing or other cost-splitting arrangements the Executive was otherwise paying immediately prior to the date of termination.

 

2. Modified Economic Cutback. Immediately following Article III, Section B of the Agreement, a new Article III, Section C as provided below is hereby added:

 

C. Adjustments Due to Excise Tax.

 

(i) Notwithstanding any other provision of this Agreement or any other plan, arrangement or agreement to the contrary, if any of the payments or benefits provided or to be provided by the Company or its affiliates to the Executive or for the Executive’s benefit pursuant to the terms of this Agreement or otherwise (“Covered Payments”) constitute parachute payments (“Parachute Payments”) within the meaning of Section 280G of the Internal Revenue Code of 1986, as amended (the “Code”), and would, but for this Article III, Section C, be subject to the excise tax imposed under Section 4999 of the Code (or any successor provision thereto) or any similar tax imposed by state or local law or any interest or penalties with respect to such taxes (collectively, the “Excise Tax”), then prior to making the Covered Payments, a calculation shall be made comparing (a) the Net Benefit (as defined below) to the Executive of the Covered Payments after payment of the Excise Tax to (b) the Net Benefit to the Executive if the Covered Payments are limited to the extent necessary to avoid being subject to the Excise Tax. Only if the amount calculated under (a) above is less than the amount under (b) above will the Covered Payments be reduced to the minimum extent necessary to ensure that no portion of the Covered Payments is subject to the Excise Tax. “Net Benefit” shall mean the present value of the Covered Payments net of all federal, state, local, foreign income, employment and excise taxes.

 

   
 

 

(ii) Any such reduction shall be made in accordance with Section 409A of the Code and the following:

 

  (a) the Covered Payments which do not constitute nonqualified deferred compensation subject to Section 409A of the Code shall be reduced first; and
     
  (b) all other Covered Payments shall then be reduced as follows: cash payments shall be reduced before non-cash payments; and payments to be made on a later payment date shall be reduced before payments to be made on an earlier payment date.

 

(iii) In the event it is determined that the Excise Tax may be imposed on the Executive prior to the possibility of any reductions being made pursuant to this Article III, Section C, the Company and the Executive agree to take such actions as they may mutually agree in writing to take to avoid any such reductions being made or, if such reduction is not otherwise required by this Article III, Section C, to reduce the amount of Excise Tax imposed.

 

(iv) The independent public accounting firm serving as the Company’s auditing firm, or such other accounting firm, law firm or professional consulting services provider of national reputation and experience reasonably acceptable to the Company and the Executive (the “Accountants”) shall make in writing in good faith all calculations and determinations under this Article III, Section C, including the assumptions to be used in arriving at any calculations. For purposes of making the calculations and determinations under this Article III, Section C, the Accountants and each other party may make reasonable assumptions and approximations concerning the application of Section 280G and Section 4999. The Company and the Executive shall furnish to the Accountants and each other such information and documents as the Accountants and each other may reasonably request to make the calculations and determinations under this Article III, Section C. The Company shall bear all costs the Accountants incur in connection with any calculations contemplated hereby.

 

3. Except as expressly amended by this Amendment, the Agreement shall continue in full force and effect in accordance with the provisions thereof

 

4. In the event of a conflict between the Agreement and this Amendment, this Amendment shall govern.

 

[Remainder of Page Intentionally Left Blank;

Signature Page Follows.]

 

   
 

 

IN WITNESS WHEREOF, the Parties have executed this Fourth Amendment to Employment Agreement as of the date first set forth above.

 

THE COMPANY:  
   
INSPIREMD, INC.  
     
By: /s/ Paul Stuka  
Name: Paul Stuka  
Title: Chairman of the Board  

 

THE EXECUTIVE:  
   
 /s/ Marvin Slosman  
Marvin Slosman  

 

   

 

EX-10.2 3 ex10-2.htm

 

Exhibit 10.2

 

EXECUTION VERSION

 

EIGHTH AMENDMENT TO EMPLOYMENT AGREEMENT

 

This EIGHTH AMENDMENT TO AMENDED AND RESTATED EMPLOYMENT AGREEMENT (this “Amendment”), is made and entered into as of April 1, 2024, by and between Craig Shore (the “Executive”) and InspireMD, Inc., a Delaware Corporation (the “Company”) for purposes of amending that certain Amended and Restated Employment Agreement dated as of May 5, 2014, as amended on January 5, 2015, July 25, 2016, March 25, 2019, August 14, 2020, November 4, 2021, January 17, 2022 and January 18, 2023, by and between the Company and the Executive (the “Agreement”). Terms used in this Amendment with initial capital letters that are not otherwise defined herein shall have the meanings ascribed to such terms in the Agreement.

 

WHEREAS, section 7.5 of the Agreement provides that the parties to the Agreement may amend the Agreement in a writing signed by the parties; and

 

WHEREAS, the Parties desire to amend the Agreement in certain respects;

 

NOW, THEREFORE, pursuant to Section 7.5 of the Agreement, and for good and valuable consideration, the sufficiency of which is hereby acknowledged, the Company and the Executive agree as follows:

 

1. Additional Payments in the event of an Employment Termination related to Change in Control. A new Section 5.3 shall be added to the Agreement as follows:

 

In the event of a Change in Control as defined by Exhibit A to the Agreement if the Executive is terminated during the three (3) month period before the Change of Control or within twelve (12) months following a Change of Control for any reason other than Cause or his Agreement is not renewed by the Company during the three months before or twelve months following a Change in Control, the Executive shall receive, subject to the execution and timely return by the Executive of a release of claims in the form to be delivered by the Company, which release shall, by its terms, be irrevocable no later than the sixtieth (60th) day following this employment termination date, the following additional Change in Control benefits: (a) severance pay equal to the Executive’s Base Salary for twelve (12) months, paid on the Company’s first regular pay date thirty days after the Executive is terminated or on the Company’s regular payroll schedule, whichever the Executive chooses in his sole discretion; (b) the equivalent of Executive’s entire Annual Bonus (defined in Section 2.3 of the Agreement) based on achievement of the applicable performance criteria/financial results in the year prior to the year of termination, paid in one lump sum on the Company’s first regular payroll pay date that occurs after the expiration of the applicable revocation period for the release; (c) the amount equal to the product of (i) the Annual Bonus, paid at 100% target, for the calendar year in which his termination of employment occurs (assuming full achievement of all applicable goals under the Bonus Plan) that he would have received had his employment not been terminated during such year and (ii) a fraction, the numerator of which is the number of days the Executive was employed by the Company during the year of termination and the denominator of which is the number of days in such year, payable at the same time as such bonuses are payable to other executives under the Bonus Plan; and (d) in addition, the Executive may exercise any future stock options or stock appreciation rights until the earlier of (x) the last date on which such stock options or stock appreciation rights could have been exercised pursuant to the terms of the applicable award agreement, irrespective of the Executive’s termination of employment; and (y) the date that is one (1) year following his employment termination date. These additional amounts shall be paid in addition to payments related to any and all social, pension, retirement, profit-sharing, severance or similar compensatory benefits, including payments pursuant to the Policy (as defined in Section 3.5) and the Education Fund (as defined in Section 3.6), owed to and/or previously deposited into the relevant accounts of or for the benefit of, the Executive as of the date of termination plus an amount equal to the sum of (A) the annual cost to the Company of providing the automobile to the Executive (i.e. car allowance) and (B) payments related to any and all social, pension, retirement, profit-sharing, severance or similar compensatory benefits, including payments pursuant to the Policy and the Education Fund, which the Company would have been obligated to pay had the Executive remained employed in the same position and at the same base salary for the 12 months immediately following the date of termination, as were in effect for the 12 months immediately preceding the date of termination. These Change in Control benefits are in addition to (but without duplication of) Executive’s severance benefits that would be triggered by terminations without a Change in Control which include: (A) one year of Base Salary: (B) the annual cost to the Company of providing the automobile to the Executive (i.e. car allowance) and (C) payments related to any and all social, pension, retirement, profit-sharing, severance or similar compensatory benefits, including payments pursuant to the Policy and the Education Fund, Manager’s Insurance, Recuperation Pay, and unused vacation days which the Company would have been obligated to pay had the Executive remained employed in the same position and at the same base salary for the twelve (12) months immediately following the date of termination, as were in effect for the twelve (12) months immediately preceding the date of termination.

 

 
 

  

Additionally, in the event of a Change in Control as defined by Exhibit A to the Agreement to the fullest extent permitted by the Company’s then-current benefit plans, Executive shall be entitled to continuation of health, dental, vision and life insurance coverage, (but not pension, retirement, profit-sharing, severance or similar compensatory benefits), for the Executive and the Executive’s eligible dependents substantially similar to coverage they were receiving or which they were entitled to immediately prior to the termination of the Executive’s employment for the lesser of 12 months after termination or until the Executive secures coverage from new employment. The period of COBRA health care continuation coverage provided under Section 4980B of the Code shall run concurrently with the foregoing 12-month period. In order to receive such benefits, the Executive or his eligible dependents must continue to make any required co-payments, deductibles, premium sharing or other cost-splitting arrangements the Executive was otherwise paying immediately prior to the date of termination, and nothing herein shall require the Company to be responsible for such items. If the Executive is a “specified employee” under Section 409A, the full cost of the continuation or provision of employee group welfare benefits (other than medical or dental benefits) shall be paid by the Executive until the earliest to occur of (i) the Executive’s death or (ii) the first day of the seventh month following the Executive’s termination of employment, and such cost shall be reimbursed by the Company to, or on behalf of, the Executive in a lump sum cash payment on the earlier to occur of the Executive’s death or the first day of the seventh month following the Executive’s termination of employment, except that, as provided above, the Executive shall not receive reimbursement for any required co-payments, deductibles, premium sharing or other cost-splitting arrangements the Executive was otherwise paying immediately prior to the date of termination.

 

2. Additionally, the definition of “Change in Control Period” in Exhibit A to the Agreement shall be replaced in its entirety as follows as follows:

 

Change in Control Period shall mean the three (3) months before or twelve (12) month period commencing on the Change in Control Date.

 

3. Except as expressly amended by this Amendment, the Agreement shall continue in full force and effect in accordance with the provisions thereof

 

4. In the event of a conflict between the Agreement and this Amendment, this Amendment shall govern.

 

[Remainder of Page Intentionally Left Blank;

Signature Page Follows.]

 

 
 

  

IN WITNESS WHEREOF, the Parties have executed this Amendment to Employment Agreement as of the date first set forth above.

 

THE COMPANY:  
   
INSPIREMD, INC.  
     
By: /s/ Paul Stuka  
Name: Paul Stuka  
Title: Chairman of the Board  

 

THE EXECUTIVE:  
   
/s/ Craig Shore  
Craig Shore, an individual  

 

 

 

EX-101.SCH 4 nspr-20240402.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 nspr-20240402_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 nspr-20240402_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 13 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 22 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://inspiremd.com/role/Cover Cover Cover 1 false false All Reports Book All Reports form8-k.htm nspr-20240402.xsd nspr-20240402_lab.xml nspr-20240402_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 15 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "form8-k.htm": { "nsprefix": "NSPR", "nsuri": "http://inspiremd.com/20240402", "dts": { "inline": { "local": [ "form8-k.htm" ] }, "schema": { "local": [ "nspr-20240402.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "nspr-20240402_lab.xml" ] }, "presentationLink": { "local": [ "nspr-20240402_pre.xml" ] } }, "keyStandard": 22, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 59, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 22 }, "report": { "R1": { "role": "http://inspiremd.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-04-02", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-04-02", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "b", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "form8-k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r14" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r14" ] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r13", "r14" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r13" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r19" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r16" ] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r14" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r17" ] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r13" ] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://inspiremd.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r18" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 16 0001493152-24-012648-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-24-012648-xbrl.zip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end XML 19 form8-k_htm.xml IDEA: XBRL DOCUMENT 0001433607 2024-04-02 2024-04-02 iso4217:USD shares iso4217:USD shares false 0001433607 8-K 2024-04-02 InspireMD, Inc. DE 001-35731 26-2123838 4 Menorat Hamaor St. Tel Aviv IL 6744832 (888) 776-6804 false false false false Common Stock, par value $0.0001 per share NSPR NASDAQ false XML 20 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Cover
Apr. 02, 2024
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Apr. 02, 2024
Entity File Number 001-35731
Entity Registrant Name InspireMD, Inc.
Entity Central Index Key 0001433607
Entity Tax Identification Number 26-2123838
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 4 Menorat Hamaor St.
Entity Address, City or Town Tel Aviv
Entity Address, Country IL
Entity Address, Postal Zip Code 6744832
City Area Code (888)
Local Phone Number 776-6804
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.0001 per share
Trading Symbol NSPR
Security Exchange Name NASDAQ
Entity Emerging Growth Company false